MST kinases monitor actin cytoskeletal integrity and signal via c-Jun N-terminal kinase stress-activated kinase to regulate p21Waf1/Cip1 stability

Molecular and Cellular Biology

Volumn 29, Issue 24, 2009, Pages 6380-6390

  Densham, Ruth M ^a,b   O'Neill, Eric ^a,c   Munro, June ^a   König, Ireen ^a   Anderson, Kurt ^a   Kolch, Walter ^a   Olson, Michael F ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; MAMMALIAN STE20 LIKE KINASE 1; MAMMALIAN STE20 LIKE KINASE 2; PHOSPHOTRANSFERASE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; CYTOSKELETON; ENZYME ACTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ACTINS; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOSKELETON; EMETINE; ENZYME ACTIVATION; ENZYME STABILITY; HELA CELLS; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 8; MUTAGENESIS, SITE-DIRECTED; NIH 3T3 CELLS; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 71949111129     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00116-09     Document Type: Article

References (59)

1. WAF1/CIP1 is upregulated by the geranylgeranyltransferase I inhibitor GGTI-298 through a transforming growth factor beta- and Sp1-responsive element: involvement of the small GTPase rhoA. Mol. Cell. Biol. 18:6962-6970.
2. Ailenberg, M., and M. Silverman. 2003. Cytochalasin D disruption of actin filaments in 3T3 cells produces an anti-apoptotic response by activating gelatinase A extracellularly and initiating intracellular survival signals. Biochim. Biophys. Acta 1593:249-258.
3. Aktories, K., C. Mohr, and G. Koch. 1992. Clostridium botulinum C3 ADP-ribosyltransferase. Curr. Top. Microbiol. Immunol. 175:115-131.
4. Altan, Z. M., and G. Fenteany. 2004. c-Jun N-terminal kinase regulates lamellipodial protrusion and cell sheet migration during epithelial wound closure by a gene expression-independent mechanism. Biochem. Biophys. Res. Commun. 322:56-67.
5. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, S. S. Bhagwat, A. M. Manning, and D. W. Anderson. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681-13686.
6. Bergo, M. O., B. J. Gavino, C. Hong, A. P. Beigneux, M. McMahon, P. J. Casey, and S. G. Young. 2004. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J. Clin. Investig. 113:539-550.
7. Bettinger, B. T., and D. C. Amberg. 2007. The MEK kinases MEKK4/Ssk2p facilitate complexity in the stress signaling responses of diverse systems. J. Cell Biochem. 101:34-43.
8. Bettinger, B. T., M. G. Clark, and D. C. Amberg. 2007. Requirement for the polarisome and formin function in Ssk2p-mediated actin recovery from oSmotic stress in Saccharomyces cerevisiae. Genetics 175:1637-1648.
9. Böhmer, R. M., E. Scharf, and R. K. Assoian. 1996. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol. Biol. Cell 7:101-111.
10. cip1 expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell Biol. 146:1255-1264.
11. Cherng, Y. G., H. C. Chang, Y. L. Lin, M. L. Kuo, W. T. Chiu, and R. M. Chen. 2008. Apoptotic insults to human chondrocytes induced by sodium nitroprusside are involved in sequential events, including cytoskeletal remodeling, phosphorylation of mitogen-activated protein kinase kinase kinase-1/c-Jun N-terminal kinase, and Bax-mitochondria-mediated caspase activation. J. Orthop. Res. 26:1018-1026.
12. Child, E. S., and D. J. Mann. 2006. The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle 5:1313-1319.
13. Cohen, P., and S. Frame. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2:769-776.
14. Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton. Oncogene 25:2708-2716.
15. Waf1/Cip1 protein stability via a cyclin D1-imposed block in proteasome-mediated degradation. EMBO J. 22:2036-2046.
16. Coleman, M. L., E. A. Sahai, M. Yeo, M. Bosch, A. Dewar, and M. F. Olson. 2001. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat. Cell Biol. 3:339-345.
17. Creasy, C. L., and J. Chernoff. 1995. Cloning and characterization of a human protein kinase with homology to Ste20. J. Biol. Chem. 270:21695-21700.
18. Danesh, F. R., M. M. Sadeghi, N. Amro, C. Philips, L. Zeng, S. Lin, A. Sahai, and Y. S. Kanwar. 2002. 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/ p21 signaling pathway: implications for diabetic nephropathy. Proc. Natl. Acad. Sci. USA 99:8301-8305.
19. Denoyelle, C., P. Albanese, G. Uzan, L. Hong, J. P. Vannier, J. Soria, and C. Soria. 2003. Molecular mechanism of the anti-cancer activity of cerivastatin, an inhibitor of HMG-CoA reductase, on aggressive human breast cancer cells. Cell Signal. 15:327-338. (Pubitemid 36071677)
20. Denoyelle, C., M. Vasse, M. Korner, Z. Mishal, F. Ganne, J. P. Vannier, J. Soria, and C. Soria. 2001. Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study. Carcinogenesis 22:1139-1148. (Pubitemid 32737327)
21. Diez, S., G. Gerisch, K. Anderson, A. Muller-Taubenberger, and T. Bretschneider. 2005. Subsecond reorganization of the actin network in cell motility and chemotaxis. Proc. Natl. Acad. Sci. USA 102:7601-7606.
22. Ding, V. W., R. H. Chen, and F. McCormick. 2000. Differential regulation of glycogen synthase kinase 3β by insulin and Wnt signaling. J. Biol. Chem. 275:32475-32481.
23. Dunn, C., C. Wiltshire, A. MacLaren, and D. A. Gillespie. 2002. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell Signal. 14:585-593. (Pubitemid 34304343)
24. Escoté, X., M. Zapater, J. Clotet, and F. Posas. 2004. Hog1 mediates cell-cycle arrest in G1 phase by the dual targeting of Sic1. Nat. Cell Biol. 6:997-1002.
25. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499-502. (Pubitemid 26044467)
26. Graves, J. D., K. E. Draves, Y. Gotoh, E. G. Krebs, and E. A. Clark. 2001. Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase MstI during CD95/Fas-induced apoptosis. J. Biol. Chem. 276:14909-14915.
27. Graves, J. D., Y. Gotoh, K. E. Draves, D. Ambrose, D. K. Han, M. Wright, J. Chernoff, E. A. Clark, and E. G. Krebs. 1998. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase MstI. EMBO J. 17:2224-2234. (Pubitemid 28171908)
28. Grollman, A. P. 1966. Structural basis for inhibition of protein synthesis by emetine and cycloheximide based on an analogy between ipecac alkaloids and glutarimide antibiotics. Proc. Natl. Acad. Sci. USA 56:1867-1874.
29. Hamel, M., D. Kanyi, M. D. Cipolle, and L. Lowe-Krentz. 2006. Active stress kinases in proliferating endothelial cells associated with cytoskeletal structures. Endothelium 13:157-170. (Pubitemid 44110582)
30. Han, S., N. Sidell, and J. Roman. 2005. Fibronectin stimulates human lung carcinoma cell proliferation by suppressing p21 gene expression via signals involving Erk and Rho kinase. Cancer Lett. 219:71-81. (Pubitemid 40203173)
31. Harvey, K., and N. Tapon. 2007. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nat. Rev. Cancer 7:182-191.
32. 1 that is cytoskeleton-dependent and MAP kinase (Erk)-independent. Exp. Cell Res. 275:255-264.
33. Jaffe, A. B., and A. Hall. 2005. Rho GTPases: biochemistry and biology. Annu. Rev. Cell Dev. Biol. 21:247-269.
34. Kaunas, R., S. Usami, and S. Chien. 2006. Regulation of stretch-induced JNK activation by stress fiber orientation. Cell Signal. 18:1924-1931. (Pubitemid 44485983)
35. Kim, G. Y., S. E. Mercer, D. Z. Ewton, Z. Yan, K. Jin, and E. Friedman. 2002. The stress-activated protein kinases p38 and JNK1 stabilize p21Cip1 by phosphorylation. J. Biol. Chem. 277:29792-29802.
36. Lee, K.-K., and S. Yonehara. 2002. Phosphorylation and dimerization regulate nucleocytoplasmic shuttling of mammalian STE20-like kinase (MST). J. Biol. Chem. 277:12351-12358.
37. Lee, Y. J., C. H. Tsai, J. J. Hwang, S. J. Chiu, T. J. Sheu, and P. C. Keng. 2009. Involvement of a p53-independent and post-transcriptional up-regulation for p21WAF/CIP1 following destabilization of the actin cytoskeleton. Int. J. Oncol. 34:581-589.
38. Liberto, M., D. Cobrinik, and A. Minden. 2002. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 21:1590-1599. (Pubitemid 34226147)
39. Matallanas, D., D. Romano, K. Yee, K. Meissl, L. Kucerova, D. Piazzolla, M. Baccarini, J. K. Vass, W. Kolch, and E. O'Neill. 2007. RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol. Cell 27:962-975. (Pubitemid 47495894)
40. Olson, M. F., A. Ashworth, and A. Hall. 1995. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269:1270-1272.
41. Olson, M. F., H. F. Paterson, and C. J. Marshall. 1998. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1. Nature 394: 295-299.
42. O'Neill, E., L. Rushworth, M. Baccarini, and W. Kolch. 2004. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 306:2267-2270. (Pubitemid 40024466)
43. Raman, M., W. Chen, and M. H. Cobb. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
44. Reshetnikova, G., R. Barkan, B. Popov, N. Nikolsky, and L. S. Chang. 2000. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein. Exp. Cell Res. 259:35-53.
45. Sahai, E., and M. F. Olson. 2006. Purification of TAT-C3 exoenzyme. Methods Enzymol. 406:128-140.
46. Sahai, E., M. F. Olson, and C. J. Marshall. 2001. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20:755-766. (Pubitemid 32167640)
47. Sampath, P., and T. D. Pollard. 1991. Effects of cytochalasin, phalloidin, and pH on the elongation of actin filaments. Biochemistry 30:1973-1980.
48. Scott, M. T., A. Ingram, and K. L. Ball. 2002. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J. 21:6771-6780.
49. Shim, J., H. Lee, J. Park, H. Kim, and E. J. Choi. 1996. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature 381:804-806. (Pubitemid 26243123)
50. Spector, I., N. R. Shochet, Y. Kashman, and A. Groweiss. 1983. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science 219:493-495. (Pubitemid 13189272)
51. Strange, K., J. Denton, and K. Nehrke. 2006. Ste20-type kinases: evolutionarily conserved regulators of ion transport and cell volume. Physiology 21: 61-68.
52. Taylor, L. K., H.-C. R. Wang, and R. L. Erikson. 1996. Newly identified stress-responsive protein kinases, Krs-1 and Krs-2. Proc. Natl. Acad. Sci. USA 93:10099-10104.
53. Ura, S., H. Nishina, Y. Gotoh, and T. Katada. 2007. Activation of the c-Jun N-terminal kinase pathway by MST1 Is essential and sufficient for the induction of chromatin condensation during apoptosis. Mol. Cell. Biol. 27: 5514-5522.
54. Walker, K., and M. F. Olson. 2005. Targeting Ras and Rho GTPases as opportunities for cancer therapeutics. Curr. Opin. Genet. Dev. 15:62-68.
55. Yue, X., T. R. Nadja, H. Xiaoman, and C. P. Jill. 2003. Association of JNK1 with p21waf1 and p53: modulation of JNK1 activity. Mol. Carcinogenesis 36:38-44. (Pubitemid 36055814)
56. Yuzyuk, T., M. Foehr, and D. C. Amberg. 2002. The MEK kinase Ssk2p promotes actin cytoskeleton recovery after osmotic stress. Mol. Biol. Cell 13:2869-2880.
57. Zhan, J., J. B. Easton, S. Huang, A. Mishra, L. Xiao, E. R. Lacy, R. W. Kriwacki, and P. J. Houghton. 2007. Negative regulation of ASK1 by p21Cip1 involves a small domain that includes serine 98 that is phosphorylated by ASK1 in vivo. Mol. Cell. Biol. 27:3530-3541.
58. Zhu, X., M. Ohtsubo, R. M. Bohmer, J. M. Roberts, and R. K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:391-403. (Pubitemid 26132537)
59. Zuckerbraun, B. S., D. A. Stoyanovsky, R. Sengupta, R. A. Shapiro, B. A. Ozanich, J. Rao, J. E. Barbato, and E. Tzeng. 2007. Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA. Am. J. Physiol. Cell Physiol. 292:C824-C831.